For a patient receiving mitoxantrone, which of the following is most concerning related to the risk of cardiotoxixity? A
Posted: Thu Jan 13, 2022 5:16 am
For a patient receiving mitoxantrone, which of the following is
most concerning related to the risk of cardiotoxixity?
A. Use of the liposomal formulation
B. Administration by bolus method
C. History of mediastinal radiation
D. Concomitant use of etoposide
most concerning related to the risk of cardiotoxixity?
A. Use of the liposomal formulation
B. Administration by bolus method
C. History of mediastinal radiation
D. Concomitant use of etoposide